DPT & Confab Complete $10-Million Capital Investment
DPT Laboratories, a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms, and Confab, a DPT company specializing in complex solids, semi-solids, and liquids, have completed a combined $10-million capital investment demonstrating their commitment to continuous improvement.
San Antonio-based DPT has invested in a new compounding suite and significant upgrades to production filling lines that will increase capacity, throughput, and precision. Additional upgrades include a remodeled front office area and enhanced security to further restrict access to the manufacturing floor and further enhance GMP compliance.
Confab, based in Montreal, made a significant investment to increase R&D capabilities with a new state-of-the-art laboratory, new equipment, and expansion of its R&D team. Confab can now offer customers pharmaceutical development capabilities ranging from formulation development and analytical method development to technology transfers at commercial scale.
“The investments in capital demonstrate our continuing commitment to provide high-quality development and manufacturing solutions to our partners,” said Paul Josephs, Senior Vice President of Sales, Marketing, and Corporate Development. “We are excited about the strong demand for our services and look forward to discussing our enhanced capabilities with our customers during DCAT week.”
DPT is a contract development and manufacturing organization (CDMO) helping pharmaceutical companies achieve clinical and commercial success. With cGMP-compliant facilities in San Antonio, TX, DPT applies a Quality-by-Design (QbD) methodology to investigate your product and discover and deliver the optimal solutions from development through commercialization. The company brings vast experience in resolving development and manufacturing challenges in semi-solids and liquids. From drug preformulation and formulation, to analytical method development and technology transfers, to production and distribution, DPT is a partner all the way through full-scale worldwide commercialization. For more information, visit www.DPTLabs.com.
Confab, a DPT company, is a fully integrated contract development and manufacturing organization (CDMO) specializing in complex solid dose, semi-solid, and liquid products. Through a thorough examination of your product and a solutions-oriented approach, the company helps you meet and exceed the pharmaceutical industry’s highest standards. Its experience spans more than 30 years and will set the basis for your success, all the way to market. For more information, visit www.Confab.com.
Total Page Views: 984
